Veliparib for the treatment of ovarian cancer.

about

Roflumilast restores cAMP/PKA/CREB signaling axis for FtMt-mediated tumor inhibition of ovarian cancer.

P2860

Q49468702-669CF458-2AB1-4C4B-B331-56102906257F

P2860

Veliparib for the treatment of ovarian cancer.

Item

http://www.wikidata.org/entity/Q38710466

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Veliparib for the treatment of ovarian cancer.

@en

type

Item

label

Veliparib for the treatment of ovarian cancer.

@en

prefLabel

Veliparib for the treatment of ovarian cancer.

@en

P1476

Veliparib for the treatment of ovarian cancer

@en

P2093

Arsenio Spinillo

http://www.w3.org/2001/XMLSchema#string

Barbara Gardella

http://www.w3.org/2001/XMLSchema#string

Mattia Dominoni

http://www.w3.org/2001/XMLSchema#string

Pier Luigi Venturini

http://www.w3.org/2001/XMLSchema#string

Stefano Bogliolo

http://www.w3.org/2001/XMLSchema#string

Valentina Musacchi

http://www.w3.org/2001/XMLSchema#string

P2860

DNA-repair pathway inhibitors for the treatment of ovarian cancer

Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancer

Failure of iniparib to inhibit poly(ADP-Ribose) polymerase in vitro

PARP inhibitors in the management of breast cancer: current data and future prospects

Profile of veliparib and its potential in the treatment of solid tumors

A phase II evaluation of the potent, highly selective PARP inhibitor veliparib in the treatment of persistent or recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer in patients who carry a germline BRCA1 or BRCA2 mutation - An

Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers.

Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy

Cancer statistics, 2008

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

P304

367-374

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/13543784.2016.1146677

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Simone Ferrero

Chiara Cassani

P577

2016-02-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26807493

http://www.w3.org/2001/XMLSchema#string

P921

ovarian cancer

Veliparib for the treatment of ovarian cancer.

about

P2860

P2860

Veliparib for the treatment of ovarian cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921